Please enable Javascript to use all features and improve your user experience.
ECV 2023
Programme
People
Search
EN
All people
Sarah Schmidt
New York, NY / US
Hookipa Pharma
Sort by Type
Date
Further involvements
7th May 2023
10:55 a.m.
–
11:10 a.m.
10 Min.
5 Min.
Abstract Talk
AT 73
Novel alternating Arenavirus-based vector technology encoding HBV antigens generates robust antigen-specific CD8 T cell responses and high titers of anti-HBsAg antibodies
Vaccines, Viral vectors
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy